EP0929696A2 - Verfahren und reagentiensatz zur erkennung und/oder quantifizierung von nukleinsäuren durch sandwich-hybridisierung an der festphase - Google Patents
Verfahren und reagentiensatz zur erkennung und/oder quantifizierung von nukleinsäuren durch sandwich-hybridisierung an der festphaseInfo
- Publication number
- EP0929696A2 EP0929696A2 EP97939883A EP97939883A EP0929696A2 EP 0929696 A2 EP0929696 A2 EP 0929696A2 EP 97939883 A EP97939883 A EP 97939883A EP 97939883 A EP97939883 A EP 97939883A EP 0929696 A2 EP0929696 A2 EP 0929696A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- nucleotide sequence
- target
- sequence
- standard
- bases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 74
- 239000007787 solid Substances 0.000 title claims abstract description 31
- 238000009396 hybridization Methods 0.000 title claims description 128
- 150000007523 nucleic acids Chemical group 0.000 title description 21
- 239000002773 nucleotide Substances 0.000 claims abstract description 242
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 242
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 55
- 230000000295 complement effect Effects 0.000 claims abstract description 42
- 239000012472 biological sample Substances 0.000 claims abstract description 12
- 108020004414 DNA Proteins 0.000 claims description 84
- 230000003321 amplification Effects 0.000 claims description 70
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 70
- 108091093088 Amplicon Proteins 0.000 claims description 63
- 238000011002 quantification Methods 0.000 claims description 50
- 238000001514 detection method Methods 0.000 claims description 47
- 238000006243 chemical reaction Methods 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 13
- 238000002372 labelling Methods 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 8
- 230000002068 genetic effect Effects 0.000 claims description 8
- 229910019142 PO4 Inorganic materials 0.000 claims description 7
- 239000011324 bead Substances 0.000 claims description 7
- 239000010452 phosphate Substances 0.000 claims description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 5
- 150000001412 amines Chemical class 0.000 claims description 3
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims description 2
- 239000000523 sample Substances 0.000 description 78
- 238000003752 polymerase chain reaction Methods 0.000 description 54
- 239000013615 primer Substances 0.000 description 42
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 33
- 239000000243 solution Substances 0.000 description 32
- 238000005259 measurement Methods 0.000 description 22
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 16
- 230000000694 effects Effects 0.000 description 15
- 108020004707 nucleic acids Proteins 0.000 description 14
- 102000039446 nucleic acids Human genes 0.000 description 14
- 239000012634 fragment Substances 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 238000010790 dilution Methods 0.000 description 12
- 239000012895 dilution Substances 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 230000002860 competitive effect Effects 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 241000725303 Human immunodeficiency virus Species 0.000 description 9
- 238000012408 PCR amplification Methods 0.000 description 9
- 238000005415 bioluminescence Methods 0.000 description 9
- 230000029918 bioluminescence Effects 0.000 description 9
- 239000000872 buffer Substances 0.000 description 9
- 230000035945 sensitivity Effects 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- 108091034117 Oligonucleotide Proteins 0.000 description 7
- 230000007423 decrease Effects 0.000 description 7
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 238000007834 ligase chain reaction Methods 0.000 description 6
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 5
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 5
- 108091000080 Phosphotransferase Proteins 0.000 description 5
- 230000000692 anti-sense effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 102000020233 phosphotransferase Human genes 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 229920000136 polysorbate Polymers 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 241000972773 Aulopiformes Species 0.000 description 4
- 108060001084 Luciferase Proteins 0.000 description 4
- 239000005089 Luciferase Substances 0.000 description 4
- 102000003992 Peroxidases Human genes 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000003757 reverse transcription PCR Methods 0.000 description 4
- 235000019515 salmon Nutrition 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 241000724252 Cucumber mosaic virus Species 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 108020005202 Viral DNA Proteins 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 125000006850 spacer group Chemical group 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 108700002232 Immediate-Early Genes Proteins 0.000 description 2
- 108020000999 Viral RNA Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000005518 electrochemistry Effects 0.000 description 2
- 238000005401 electroluminescence Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000011325 microbead Substances 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000000163 radioactive labelling Methods 0.000 description 2
- 239000011535 reaction buffer Substances 0.000 description 2
- 230000036632 reaction speed Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- -1 0.2 mM of dNTPs Substances 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000713838 Avian myeloblastosis virus Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000606153 Chlamydia trachomatis Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001430197 Mollicutes Species 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- 108091027568 Single-stranded nucleotide Proteins 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241000589596 Thermus Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- FXAGBTBXSJBNMD-UHFFFAOYSA-N acetic acid;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound CC(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O FXAGBTBXSJBNMD-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 150000001615 biotins Chemical class 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 238000002680 cardiopulmonary resuscitation Methods 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 1
- DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 230000005476 size effect Effects 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
Definitions
- the labeled nucleotide sequence will be immobilized if the target or standard nucleotide sequence is present and immobilized on a trapping nucleotide sequence.
- the target or standard nucleotide sequence is then sandwiched between the nucleotide sequence trapper and the nucleotide sequence marked, by a double recognition, which increases the specificity, reduces the background noise, and allows a quantification of the nucleotide sequences. This is only possible if the hybridization is carried out quantitatively and reproducibly. This is all the more true as the yield from this hybridization is high.
- the target and standard nucleotide sequences to be detected and / or quantified consist of any type of nucleic acid, DNA or RNA.
- the trapped, "helper”, labeled and standard nucleotide sequences used according to the present invention consist of DNA so as to avoid any destruction of these sequences by RNase possibly present in the biological sample. .
- the term “content in close GC / AT bases” is understood to mean that the ratio of GC / AT bases of the standard is less than 20% of the ratio of GC / AT bases of the target nucleotide sequence.
- the nucleotide sequence labeled has a length sufficient to specifically recognize the target or standard nucleotide sequence to be detected and / or quantified, this specificity depending on the type of target or standard nucleotide sequence to be detected and / or quantified, and can be characterized by recognition by hybridization a specific complementary portion of at least 10 bases, preferably more than 20 bases, of the target or standard nucleotide sequence.
- FIG. 7 is a schematic description of the principle of the quantification of a target DNA by using a competitive standard according to the invention and their respective measurement by specific probes after capture on a common immobilized sequence.
- Another property of the method and of the kit of the invention is the advantageous use of trapping nucleotide sequences having a minimum size of 50 bases if possible 100 and at best 150 or more bases. This observation is unexpected based on the following considerations.
- the stability of the hybrids in the case where the ionic strength is constant and the size sufficient (beyond 50 cells), only depends on the composition (% G + C i and not on the size of the hybrids
- the importance of the size to favor or not the hybridization depends on the speed of the hybridization and not on their stability. Indeed, in solution, the size of the nucleic acid strands influences the rate of re-pairing. This is proportional to the square root of the length (Wetmur, JG and Davidson, N. 1968, J. Mol. Biol.
- the target nucleotide sequence even after sandwich hybridization keeps a free sequence, this can always serve as a pairing site for the other strand of the complementary target nucleotide sequence, which will destabilize the hybrid and may even dissociate according to the experimental conditions (temperature, salts, etc.), because once the pairing has started, the propagation of the formation of the double strand is very rapid and thermodynamically favorable.
- this sandwich hybridization also allows quantification of these two amplicons with the same efficiency by operating as follows: the preparation containing the 2 amplicons is diluted adequately and is added to 2 or a double series of wells
- Two types of trappers were used, corresponding to 180 and 360 bases complementary to the amplicon sequence.
- the hybridizations were carried out in the presence of increasing concentrations of target amplicons at 45 ° C. for 2 hours in a solution consisting of SSC 2x concentrated, ⁇ e Denhart 5x concentrated, Denatured salmon sperm DNA at 0.1 mg / ml.
- the kinase activity is revealed in 20 mM Tris buffer pH 7.75 containing 60 ⁇ M DTT, 100 ⁇ M EDTA, 5 mM MgCl 2 , 8 ⁇ M Luciferine, 6 mU luciferase per 20 mM KCl well, 1 mM Phosphoenolpyruvate and ADP 3.2 ⁇ M.
- the light emission is followed for one hour with a luminometer (Lum oskan, Labsystem, Finland) and the results are expressed in RLU. mm.
- Example 6 Differential hybridization of a small and a
- tubes are prepared containing increasing concentrations of external standard as defined in FIG. 5. All the tubes have undergone a PCR of 40 cycles using primers corresponding to the sequence
- 0.1 ml included 100 pmol of each of the 2 primers, 200 mM of the various dNTPs and 2.5 U of Taq DNA polymerase in a 10 mM TRIS-HCl buffer pH 8.4 with 1.5 mM MgCl 2 and KCl
- Each point represents the average of 3 measurements. There is a correlation between the number of starting copies and the signal obtained. In addition, the curves obtained for the target and the standard are very close, which makes it possible to use the curve of the standard as a reference for determining the number of copies of the target DNA CMV in the starting sample.
- the composition of the internal standard is given in FIG. 5.
- Each tube was subjected to amplification by 40 cycles of PCR under the conditions presented in example 15 using the primers corresponding to the sequence 3191-3217 and 3504-3481 of CMV gene ( Figure 5). After amplification, 314 base pair amplicons corresponding to the CMV target and to the standard are therefore obtained. From each of the PCR solutions, 0.04 ml are taken and incubated in 2 wells containing an identical trapper for the common sequences " of the 2 amplicons. In one of the wells, is added the biotinylated 40 base probe specific for the CMV target and in the other, the 40-base biotinylated probe specific for the standard.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE9600755 | 1996-09-09 | ||
| BE9600755A BE1010608A3 (fr) | 1996-09-09 | 1996-09-09 | Procede de quantification d'une sequence d'acides nucleiques. |
| BE9700244 | 1997-03-20 | ||
| BE9700244A BE1011052A3 (fr) | 1997-03-20 | 1997-03-20 | Procede et trousse de diagnostic et/ou de quantification par hybridation de type sandwich de sequences d'acides nucleiques sur support solide. |
| PCT/BE1997/000102 WO1998011253A2 (fr) | 1996-09-09 | 1997-09-09 | Procede et trousse de diagnostic et/ou de quantification par hybridation de type sandwich de sequences d'acides nucleiques sur support solide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP0929696A2 true EP0929696A2 (de) | 1999-07-21 |
Family
ID=25663054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP97939883A Withdrawn EP0929696A2 (de) | 1996-09-09 | 1997-09-09 | Verfahren und reagentiensatz zur erkennung und/oder quantifizierung von nukleinsäuren durch sandwich-hybridisierung an der festphase |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP0929696A2 (de) |
| WO (1) | WO1998011253A2 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1096024A1 (de) * | 1999-10-28 | 2001-05-02 | Remacle, José | Verfahren und Reagentiensatz zum Auswählen und/oder Quantifizieren von multiplen homologen Nukleinsäuresequenzen unter Verwendung von Sondenanordnungen |
| US7205104B2 (en) * | 2000-03-24 | 2007-04-17 | Eppendorf Array Technologies Sa (Eat) | Identification of biological (micro) organisms by detection of their homologous nucleotide sequences on arrays |
| US7202026B2 (en) | 2000-03-24 | 2007-04-10 | Eppendorf Array Technologies Sa (Eat) | Identification of a large number of biological (micro)organisms groups at different levels by their detection on a same array |
| US7829313B2 (en) | 2000-03-24 | 2010-11-09 | Eppendorf Array Technologies | Identification and quantification of a plurality of biological (micro)organisms or their components |
| US7875442B2 (en) | 2000-03-24 | 2011-01-25 | Eppendorf Array Technologies | Identification and quantification of a plurality of biological (micro)organisms or their components |
| EP1164201A1 (de) * | 2000-06-14 | 2001-12-19 | Facultés Universitaires Notre-Dame de la Paix | Umgekehrter nachweis zur Identifizierung und/oder Quantifizierung von Nukleotid-Zielsequenzen mittels Biochips |
| EP2441520A1 (de) | 2010-10-12 | 2012-04-18 | Eppendorf AG | Echtzeitverstärkungs- und Mikroarray-basierte Erkennung von Nukleinsäuretargets in einem Fluss-Chip-Assay |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5213961A (en) * | 1989-08-31 | 1993-05-25 | Brigham And Women's Hospital | Accurate quantitation of RNA and DNA by competetitive polymerase chain reaction |
| GB9016163D0 (en) * | 1990-07-24 | 1990-09-05 | Cemu Bioteknik | Chemical method |
| FR2683827B1 (fr) * | 1991-11-15 | 1994-03-04 | Institut Nal Sante Recherc Medic | Procede de determination de la quantite d'un fragment d'adn d'interet par une methode d'amplification enzymatique. |
| ZA936015B (en) * | 1992-08-24 | 1994-03-10 | Akzo Nv | Elimination of false negatives in nuleic acid detection. |
| AU5298393A (en) * | 1992-10-08 | 1994-05-09 | Regents Of The University Of California, The | Pcr assays to determine the presence and concentration of a target |
| WO1996009407A1 (en) * | 1994-09-21 | 1996-03-28 | Pharmacia Biosensor Ab | Process for quantification of nucleic acids |
-
1997
- 1997-09-09 EP EP97939883A patent/EP0929696A2/de not_active Withdrawn
- 1997-09-09 WO PCT/BE1997/000102 patent/WO1998011253A2/fr not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO9811253A3 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998011253A2 (fr) | 1998-03-19 |
| WO1998011253A3 (fr) | 1998-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0713922B1 (de) | Oligonukleotid verwendbar als Primer in einem Amplifikationsverfahren auf der Basis einer Strangverdrängungsreplikation | |
| CA2145533C (fr) | Procede d'amplification d'acides nucleiques par transcription utilisant le deplacement, reactifs et necessaire pour la mise en oeuvre de ce procede | |
| WO1991019812A1 (fr) | Procede de detection d'une sequence nucleotidique selon la technique d'hybridation sandwich | |
| EP0569272A1 (de) | Einstufiges Amplifikationsverfahren für RNS | |
| CH647870A5 (fr) | Procede d'analyse d'une sequence ou fragment determine d'acide nucleique et moyens de mise en oeuvre du procede. | |
| WO1997005277A1 (fr) | Procede de detection d'acides nucleiques utilisant des sondes nucleotidiques permettant a la fois une capture specifique et une detection | |
| FR2683827A1 (fr) | Procede de determination de la quantite d'un fragment d'adn d'interet par une methode d'amplification enzymatique. | |
| WO2011134332A1 (zh) | 基于微阵列芯片的多重pcr测定 | |
| FR2723950A1 (fr) | Fragments nucleotidiques capables de s'hybrider specifiquemennt a l'adnr ou arnr des rickettsia et leur utilisation comme sondes ou amorces. | |
| EP0407291A1 (de) | Verfahren zur Verstärkung von Nukleinsäuren | |
| EP2212820B1 (de) | Echtzeitmessung einer population von nukleinsäuren, insbesondere durch pcr | |
| Kim et al. | Colorimetric molecular diagnosis of the HIV gag gene using DNAzyme and a complementary DNA-extended primer | |
| WO1998011253A2 (fr) | Procede et trousse de diagnostic et/ou de quantification par hybridation de type sandwich de sequences d'acides nucleiques sur support solide | |
| JP2012501174A (ja) | インピーダンス分光法を用いたdnaの測定 | |
| BE1010608A3 (fr) | Procede de quantification d'une sequence d'acides nucleiques. | |
| Ermini et al. | Single nucleotide polymorphism detection by optical DNA-based sensing coupled with whole genomic amplification | |
| WO1992016654A1 (fr) | Detection non radioactive de la presence d'un acide nucleique determine dans un echantillon biologique | |
| BE1011052A3 (fr) | Procede et trousse de diagnostic et/ou de quantification par hybridation de type sandwich de sequences d'acides nucleiques sur support solide. | |
| Li et al. | Sensitive fluorescent sensor for recognition of HIV‐1 dsDNA by using glucose oxidase and triplex DNA | |
| WO2018202904A1 (fr) | Procede in vitro de detection et de quantification de l'adn du vih-2 | |
| EP0720660B1 (de) | Enzymatische vervielfaeltigung eines dna-fragments in vitro mittels einem treppenformigen anfangsstueck | |
| FR3106834A1 (fr) | Nouveau procédé de PCR multiplexe et utilisation | |
| EP1330542B1 (de) | Methode zum schnellnachweis von organismen in einer probe | |
| BE1032304B1 (fr) | Procédés et outils de détection d'espèces de plasmodium et d'un virus de la grippe et leur utilisation | |
| FR2733515A1 (fr) | Tampon, procede et methode d'evaluation des conditions optimales, d'amplification de sequences cibles d'acide nucleique, et leurs applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19990331 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): BE CH DE FR GB IT LI NL |
|
| 17Q | First examination report despatched |
Effective date: 20030409 |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: EPPENDORF ARRAY TECHNOLOGIES (E.A.T.) |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: ERNEST, ISABELLE Inventor name: ZAMMATTEO, NATHALIE Inventor name: ALEXANDRE, ISABELLE Inventor name: REMACLE, JOSE |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
| 18W | Application withdrawn |
Effective date: 20050527 |